Immunohistochemical evaluation of versican, in relation to chondroitin sulphate, in canine mammary tumours

Histology and Histopathology

Volumn 18, Issue 4, 2003, Pages 1067-1080

  Erdelyi I ^a   Nieskens, D H M ^a   Van Dijk, J E ^a   Vass, L ^b   Nederbragt, H ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b Flor Ferenc Hospital   (Hungary)

Author keywords

Canine mammary tumour; Chondroitin sulphate; Extracellular matrix; Proteoglycan; Versican

Indexed keywords

CHONDROITIN SULFATE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 12C5; MONOCLONAL ANTIBODY 2B1; MONOCLONAL ANTIBODY CS56; N ACETYLGALACTOSAMINE 4 SULFATASE; PROTEOGLYCAN; UNCLASSIFIED DRUG; VERSICAN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BASEMENT MEMBRANE; BENIGN TUMOR; BREAST; BREAST TUMOR; CELL INVASION; CELL PROLIFERATION; CONTROLLED STUDY; DIGESTION; DOG; EXPERIMENTAL MODEL; EXTRACELLULAR MATRIX; IMMUNOHISTOCHEMISTRY; IMMUNOLOCALIZATION; IMMUNOREACTIVITY; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; PROTEIN EXPRESSION; SPINDLE CELL;

ANIMALS; ANTIBODIES, MONOCLONAL; CARCINOMA; CARCINOMA, PAPILLARY; CHONDROITIN SULFATES; CONNECTIVE TISSUE; DOGS; FEMALE; IMMUNOHISTOCHEMISTRY; LECTINS, C-TYPE; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, EXPERIMENTAL; MIXED TUMOR, MALIGNANT; NEOPLASM INVASIVENESS; PROTEOCHONDROITIN SULFATES; SKIN; VERSICANS;

ANIMALIA; CANIS FAMILIARIS;

EID: 17144466390     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Adany R. and Iozzo R.V. (1990). Altered methylation of versican proteoglycan gene in human colon carcinoma. Biochem. Biophys. Res. Commun. 171, 1402-1413.
2. Asher R., Perides G., Vanderhaeghen J.J. and Bignami A. (1991). Extracellular matrix of central nervous system white matter: Demonstration of an hyaluronate-protein complex. J. Neurosci. Res. 28, 410-421.
3. Aspberg A., Adam S., Kostka G., Timpl R. and Heinegard D. (1999). Fibulin-1 is a ligand for the C-type lectin domains of aggrecan and versican. J. Biol. Chem. 274, 20444-20449.
4. Aspberg A., Miura R., Bourdoulous S., Shimonaka M., Heinegard D., Schachner M., Ruoslahti E. and Yamaguchi Y. (1997). The C-type lectin domains of lecticans, a family of aggregating chondroitin sulfate proteoglycans, bind tenascin-R by protein-protein interactions independent of carbohydrate moiety. Proc. Natl. Acad. Sci. USA. 94, 10116-10121.
5. Avnur Z. and Geiger B. (1984). Immunocytochemical localization of native chondroitin-sulfate in tissues and cultured cells using specific monoclonal antibody. Cell 38, 811-822.
6. Bignami A., Hosley M. and Dahl D. (1993). Hyaluronic acid and hyaluronic acid-binding proteins in brain extracellular matrix. Anat. Embryol. (Berl.) 188, 419-433.
7. Bode-Lesniewska B., Dours-Zimmermann MT., Odermatt B.F., Briner J., Heitz P.U. and Zimmermann D.R. (1996). Distribution of the large aggregating proteoglycan versican in adult human tissues. J. Histochem. Cytochem. 44, 303-312.
8. Dours-Zimmermann M.T. and Zimmermann D.R. (1994). A novel glycosaminoglycan attachment domain identified in two alternative splice variants of human versican. J. Biol. Chem. 269, 32992-32998.
9. Du Cros D.L., LeBaron R.G. and Couchman J.R. (1995). Association of versican with dermal matrices and its potential role in hair follicle development and cycling. J. Invest. Dermatol. 105, 426-431
10. Ferguson J.E., Schor A.M., Howell A. and Ferguson M.W. (1992). Changes in the extracellular matrix of the normal human breast during the menstrual cycle. Cell Tissue Res. 268, 167-177.
11. Hinrichs U., Rutteman G.R. and Nederbragt H. (1999). Stromal accumulation of chondroitin sulphate in mammary tumours of dogs. Br. J. Cancer 80, 1359-1365.
12. Iozzo R.V. (1998). Matrix proteoglycans: From molecular design to cellular function. Annu. Rev. Biochem. 67, 609-652.
13. Isogai Z., Aspberg A., Keene D.R., Ono R.N., Reinhardt D.P. and Sakai L.Y. (2002). Versican interacts with fibrillin-1 and links extracellular microfibrils to other connective tissue networks. J. Biol. Chem. 277, 4565-4572.
14. Ito K., Shinomura T., Zako M., Ujita M. and Kimata K. (1995). Multiple forms of mouse PG-M, a large chondroitin sulfate proteoglycan generated by alternative splicing. J. Biol. Chem. 270, 958-965.
15. Kjellen L. and Lindahl U. (1991). Proteoglycans: Structures and interactions. Annu. Rev. Biochem. 60, 443-475.
16. Lark M.W., Bayne E.K., Flanagan J., Harper C.F., Hoerrner L.A., Hutchinson M.I., Singer I.I., Donatelli S.A., Weidner J.R., Williams H.R., Mumford R.A. and Lohmander L.S. (1997). Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints. J. Clin. Invest. 100, 93-106.
17. LeBaron R.G., Zimmermann D.R. and Ruoslahti E. (1992). Hyaluronate binding properties of versican. J. Biol. Chem. 267, 10003-10010.
18. Lemire J.M., Braun K.R., Maurel P., Kaplan E.D., Schwartz S.M. and Wight T.N. (1999). Versican/PG-M isoforms in vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 19, 1630-1639.
19. Margolis R.U. and Margolis R.K. (1994). Aggrecan-versican-neurocan family proteoglycans. Methods Enzymol. 245, 105-126.
20. Merrilees M.J., Lemire J.M., Fischer J.W., Kinsella M.G., Braun K.R., Clowes A.W. and Wight T.N. (2002). Retrovirally mediated overexpression of versican V3 by arterial smooth muscle cells induces tropoelastin synthesis and elastic fiber formation in vitro and in neointima after vascular injury. Circ. Res. 90, 481-487.
21. Misdorp W., Else R.W., Hellmén E. and Lipscomb T.P. (1999). Histological classification of mammary tumours of the dog and the cat. WHO International Histological Classification of Tumors of Domestic Animals. 2nd ed. Shulmann F.Y. (ed). Armed Forced Institute of Pathology, Washington, D.C. pp 11-48.
22. Nakashima N., Sobue M., Fukata S., Fukatsu T., Nagasaka T., Ohiwa N., Nara Y., Lai S. and Takeuchi J. (1990). Immunohistochemical characterization of extracellular matrix components of yolk sac tumors. Virchows Arch. B Cell Pathol. Incl. Mol. Pathol. 58, 309-315.
23. Nara Y., Kato Y., Torii Y., Tsuji Y., Nakagaki S., Goto S., Isobe H., Nakashima N. and Takeuchi J. (1997). Immunohistochemical localization of extracellular matrix components in human breast tumours with special reference to PG-M/versican. Histochem. J. 29, 21-30.
24. Nelson L.W. and Kelly W.A. (1974). Changes in canine mammary gland histology during the estrous cycle. Toxicol. Appl. Pharmacol. 27, 113-122.
25. Ohiwa N., Fukata S., Fukatsu T., Nagasaka T., Nara Y., Lai S., Nakashima N. and Takeuchi J. (1991). Immunohistochemical localization of proteoglycans in non-epithelial tumor tissues. Connect. Tissue. Res. 22, 11-19.
26. Palmer T.E. and Monlux A.W. (1979). Acid mucopolysaccharides in mammary tumors of dogs. Vet. Pathol. 16, 493-509.
27. Paulus W., Baur I., Dours-Zimmermann MT. and Zimmermann D.R. (1996). Differential expression of versican isoforms in brain tumors. J. Neuropathol. Exp. Neurol. 55, 528-533.
28. Ricciardelli C., Brooks J.H., Suwiwat S., Sakko A.J., Mayne K., Raymond W.A., Seshadri R., LeBaron R.G. and Horsfall D.J. (2002). Regulation of stromal versican expression by breast cancer cells and importance to relapse-free survival in patients with node-negative primary breast cancer. Clin. Cancer Res. 8, 1054-1060.
29. Ricciardelli C., Mayne K., Sykes P.J., Raymond W.A., McCaul K., Marshall V.R. and Horsfall D.J. (1998). Elevated levels of versican but not decorin predict disease progression in early-stage prostate cancer. Clin. Cancer Res. 4, 963-971.
30. Ruoslahti E. (1989). Proteoglycans in cell regulation. J. Biol. Chem. 264, 13369-13372.
31. Sandy J.D., Westling J., Kenagy R.D., Iruela-Arispe M.L., Verscharen C., Rodriguez-Mazaneque J.C., Zimmermann D.R., Lemire J.M., Fischer J.W., Wight T.N. and Clowes A.W. (2001). Versican V1 proteolysis in human aorta in vivo occurs at the Glu441-Ala442 bond, a site that is cleaved by recombinant ADAMTS-1 and ADAMTS-4. J. Biol. Chem. 276, 13372-13378.
32. Shinomura T., Zako M., Ito K., Ujita M. and Kimata K. (1995). The gene structure and organization of mouse PG-M, a large chondroitin sulfate proteoglycan - Genomic background for the generation of multiple PG-M transcripts. J. Biol. Chem. 270, 10328-10333.
33. Silberstein G.B. and Daniel C.W. (1982). Glycosaminoglycans in the basal lamina and extracellular matrix of the developing mouse mammary duct. Dev. Biol. 90, 215-222.
34. Sobue M., Nakashima N., Fukatsu T., Nagasaka T., Fukata S., Ohiwa N., Nara Y., Ogura T., Katoh T. and Takeuchi J. (1989). Production and immunohistochemical characterization of a monoclonal antibody raised to proteoglycan purified from a human yolk sac tumour. Histochem. J. 21, 455-460.
35. Touab M., Villena J., Barranco C., Arumi-Uria M. and Bassols A. (2002). Versican is differentially expressed in human melanoma and may play a role in tumor development. Am. J. Pathol. 160, 549-557.
36. Ujita M., Shinomura T., Ito K., Kitagawa Y. and Kimata K. (1994). Expression and binding-activity of the carboxyl-terminal portion of the core protein of PG-M, a large chondroitin sulfate proteoglycan. J. Biol. Chem. 269, 27603-27609.
37. Umbreit J.N. (1996). Proteoglycans and glycosaminoglycans during maturation of the mouse mammary gland. Anticancer Res. 16, 3013-3029.
38. Vilim V. and Fosang A.J. (1994). Proteoglycans isolated from dissociative extracts of differently aged human articular cartilage: Characterization of naturally occurring hyaluronan-binding fragments of aggrecan. Biochem. J. 304, 887-894.
39. Vogel P.M., Georgiade N.G., Fetter B.F., Vogel F.S. and McCarty K.S. (1981). The correlation of histologic changes in the human breast with the menstrual cycle. Am. J. Pathol. 104, 23-34.
40. Wu Y., Chen L., Zheng P.S. and Yang B.B. (2002). Beta 1-integrin-mediated glioma cell adhesion and free radical-induced apoptosis are regulated by binding to a C-terminal domain of PG-M/versican. J. Biol. Chem. 277, 12294-12301.
41. Yamagata M., Suzuki M., Akiyama S.K., Yamada K.M. and Kimata K. (1989). Regulation of cell-substrate adhesion by proteoglycans immobilized on extracellular substrates. J. Biol. Chem. 264, 8012-8018.
42. Yamagata M., Shinomura T. and Kimata K. (1993). Tissue variation of two large chondroitin sulfate proteoglycans (PG-M/versican and PG-H/aggrecan) in chick embryos. Anat. Embryol. (Berl.) 187, 433-444.
43. Yamauchi S., Cheng H., Neame P., Caterson B. and Yamauchi M. (1997). Identification, partial characterization, and distribution of versican and link protein in bovine dental pulp. J. Dent. Res. 76, 1730-1736.
44. Yang B.L., Zhang Y., Cao L. and Yang B.B. (1999). Cell adhesion and proliferation mediated through the G1 domain of versican. J. Cell Biochem. 72, 210-220.
45. Yao L.Y., Moody C., Schonherr E., Wight T.N. and Sandell L.J. (1994). Identification of the proteoglycan versican in aorta and smooth muscle cells by DNA sequence analysis, in situ hybridization and immunohistochemistry. Matrix Biol. 14, 213-225.
46. Zako M., Shinomura T., Ujita M., Ito K. and Kimata K. (1995). Expression of PG-M(V3), an alternatively spliced form of PG-M without a chondroitin sulfate attachment region in mouse and human tissues. J. Biol. Chem. 270, 3914-3918.
47. Zhang H., Kelly G., Zerillo C., Jaworski D.M. and Hockfield S. (1998). Expression of a cleaved brain-specific extracellular matrix protein mediates glioma cell invasion in vivo. J. Neurosci. 18, 2370-2376.
48. Zhang Y., Cao L., Yang B.L. and Yang B.B. (1998). The G3 domain of versican enhances cell proliferation via epidermial growth factor-like motifs. J. Biol. Chem. 273, 21342-21351.
49. Zhao M., Takata T., Ogawa I., Yada T., Kimata K. and Nikai H. (1999). Immunohistochemical evaluation of the small and large proteoglycans in pleomorphic adenoma of salivary glands. J. Oral. Pathol. Med. 28, 37-42.
50. Zimmermann D.R., Dours-Zimmermann M.T., Schubert M. and Bruckner-Tuderman L. (1994). Versican is expressed in the proliferating zone in the epidermis and in association with the elastic network of the dermis. J. Cell Biol. 124, 817-825.